KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

NovoCure (NVCR) Other Gross PP&E Adjustments (2016 - 2025)

NovoCure's Other Gross PP&E Adjustments history spans 12 years, with the latest figure at $48.3 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 2.03% year-over-year to $48.3 million; the TTM value through Dec 2025 reached $48.3 million, up 2.03%, while the annual FY2025 figure was $48.3 million, 2.03% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $48.3 million at NovoCure, up from -$48.4 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $48.3 million in Q4 2025 and bottomed at -$48.5 million in Q1 2025.
  • The 5-year median for Other Gross PP&E Adjustments is -$19.7 million (2022), against an average of -$15.7 million.
  • The largest annual shift saw Other Gross PP&E Adjustments soared 347.62% in 2023 before it plummeted 70.85% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $876000.0 in 2021, then skyrocketed by 205.14% to $2.7 million in 2022, then surged by 347.62% to $12.0 million in 2023, then skyrocketed by 295.99% to $47.4 million in 2024, then grew by 2.03% to $48.3 million in 2025.
  • Per Business Quant, the three most recent readings for NVCR's Other Gross PP&E Adjustments are $48.3 million (Q4 2025), -$48.4 million (Q3 2025), and -$48.1 million (Q2 2025).